Infantile hypophosphatasia: Transplantation therapy trial using bone fragments and cultured osteoblasts

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 8, 2007, Pages 2923-2930

  Cahill, Richard A ^a   Wenkert, Deborah ^b   Perlman, Sharon A ^c   Steele, Ann ^c   Coburn, Stephen P ^d   McAlister, William H ^e   Mumm, Steven ^b,f   Whyte, Michael P ^b,f  

^a Cardinal Glennon Hospital   (United States)

^b SHRINERS HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d INDIANA UNIVERSITY PURDUE UNIVERSITY FORT WAYNE   (United States)

^e ST LOUIS CHILDREN S HOSPITAL   (United States)

^f BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE ISOENZYME;

ARTICLE; BONE MINERALIZATION; BONE TRANSPLANTATION; CASE REPORT; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELL POPULATION; CLINICAL FEATURE; FEMALE; GRAFT RECIPIENT; HUMAN; HYPOPHOSPHATASIA; OSTEOBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34547743240     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2131     Document Type: Article

References (71)

1. Whyte MP 2001 Hypophosphatasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 5313-5329
2. Whyte MP 1994 Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439-461
3. Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP 1992 Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci USA 89:9924-9928
4. Anderson HC, Hsu HH, Morris DC, Fedde KN, Whyte MP 1997 Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 151:1555-1561
5. Cai G, Michigami T, Yamamoto T, Yasui N, Satomura K, Yamagata M, Shima M, Nakajima S, Mushiake S, Okada S, Ozono K 1998 Analysis of localization of mutated tissue-nonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras. J Clin Endocrinol Metab 83:3936-3942
6. Ho AM, Johnson MD, Kingsley DM 2000 Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289:265-270
7. -/- mice. J Bone Miner Res 21:1377-1386
8. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR, Whyte MP 1999 Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015-2026
9. Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH, Millan JL 2000 Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15:1879-1888
10. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millan JL 2004 Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164:841-847
11. Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G 2005 Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093-1104
12. Robison R, Soames KM 1924 The possible significance of hexosephosphoric esters in ossification. Part II. The phosphoric esterase of ossifying cartilage. Biochem J 18:740-754
13. Mornet E 2006 Tissue non-specific alkaline phosphatase gene mutations database. Accessed October 20, 2006, at http://www.sesep.uvss.fr/ database_hypo/hypophosphatasia.html
14. Whyte MP, McAlister WH, Patton LS, Magill HL, Fallon MD, Lorentz Jr WB, Herrod HG 1984 Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. J Pediatr 105:926-933
15. Whyte MP, Magill HL, Fallon MD, Herrod HG 1986 Infantile hypophosphatasia: normalization of circulating bone alkaline phosphatase activity followed by skeletal remineralization. Evidence for an intact structural gene for tissue nonspecific alkaline phosphatase. J Pediatr 108:82-88
16. Whyte MP, Habib D, Coburn SP, Tecklenburg F, Ryan L, Fedde KN, Stinson RA 1992 Failure of hyperphosphatesemia by intravenous infusion of purified placental alkaline phosphatase (ALP) to correct severe hypophosphatasia: evidence against a role for circulating ALP in skeletal mineralization. J Bone Miner Res 7:S155 (Abstract)
17. Fedde KN, Cole DE, Whyte MP 1990 Pseudohypophosphatasia: aberrant localization and substrate specificity of alkaline phosphatase in cultured skin fibroblasts. Am J Hum Genet 47:776-783
18. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R 2000 Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 279:R1365-R1377
19. Whyte MP, Kurtzberg J, McAlister WH, Mumm S, Podgornik MN, Coburn SP, Ryan LM, Miller CR, Gottesman GS, Smith AK, Douville J, Waters-Pick B, Armstrong RD, Martin PL 2003 Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18:624-636
20. Fedde KN, Blair L, Terzic F, Anderson HC, Narisawa S, Millan JL, Whyte MP 1996 Amelioration of the skeletal disease in hypophosphatasia by bone marrow transplantation using the alkaline phosphatase-knockout mouse model. Am J Hum Genet 59:A15
21. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W 2002 Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215-222
22. Koc ON, Peters C, Aubourg P, Raghavan S, Dyhouse S, DeGasperi R, Kolodny EH, Yoseph YB, Gerson SL, Lazarus HM, Caplan AI, Watkins PA, Krivit W 1999 Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 27:1675-1681
23. Awaya N, Rupert K, Bryant E, Torok-Storb B 2002 Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol 30:937-942
24. Lee WY, Cho SW, Oh ES, Oh KW, Lee JM, Yoon KH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC 2002 The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 87:329-335
25. Aubin JE 1998 Bone stem cells. J Cell Biochem Suppl 31:73-82
26. Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, Ogawa R, Good RA, Ikehara S 1994 Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 152:3119-3127
27. Hisha H, Nishino T, Kawamura M, Adachi S, Ikehara S 1995 Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 23:347-352
28. Li Y, Hisha H, Inaba M, Lian Z, Yu C, Kawamura M, Yamamoto Y, Nishio N, Toki J, Fan H, Ikehara S 2000 Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection. Exp Hematol 28:950-960
29. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben-Tal O, Eldor A, Or R 1998 Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756-763
30. Robey PG, Termine JD 1985 Human bone cells in vitro. Calcif Tissue Int 37:453-460
31. El-Badri NS, Wang BY, Cherry, Good RA 1998 Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol 26:110-116
32. Chen XD, Qian HY, Neff L, Satomura K, Horowitz MC 1999 Thy-1 antigen expression by cells in the osteoblast lineage. J Bone Miner Res 14:362-375
33. Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffiths BL, Goodfellow PN, Fellous M 1990 Genetic evidence equating SRY and the testis-determining factor. Nature 348:448-450
34. Fiegler H, Knabel M, Franz M, Kolb HJ, Just U 2002 Determination of donor-type chimerism using a semi-quantitative PCR-based method in a canine model for bone marrow transplantation. Vet Immunol Immunopathol 84:61-70
35. Cahill RA, Jones OY, Klemperer M, Steele A, Mueller TO, el-Badri N, Chang Y, Good RA 2004 Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells. Biol Blood Marrow Transplant 10:709-717
36. Cheung CP, Suhadolnik RJ 1977 Analysis of inorganic pyrophosphate at the picomole level. Anal Biochem 83:61-63
37. Mahuren JD, Coburn SP 1990 B6 vitamers: cation exchange HPLC. J Nutr Biochem 1:659-663
38. Mumm S, Jones J, Finnegan P, Henthorn P, Podgornik MN, Whyte MP 2002 Denaturing gradient gel electrophoresis analysis of the tissue non-specific alkaline phosphatase isoenzyme gene in hypophosphatasia. Mol Genet Metab 75:143-153
39. den Dunnen JT, Antonarakis SE 2001 Nomenclature for the description of human sequence variations. Hum Genet 109:121-124
40. Zurutuza L, Muller F, Gibrat JF, Taillandier A, Simon-Bouy B, Serre JL, Mornet E 1999 Correlations of genotype and phenotype in hypophosphatasia. Hum Mol Genet 8:1039-1046
41. Whyte MP, Landt M, Ryan LM, Mulivor RA, Henthorn PS, Fedde KN, Mahuren JD, Coburn SP 1995 Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Invest 95:1440-1445
42. Prockop DJ 1997 Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74
43. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T 2002 Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937
44. Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Norden-Lindeberg S, Jansson M, Dalton A, Astrom E, Westgren M 2005 Fetal mesenchymal stem cell engraftment in bone following in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607-1614
45. Marini JC 1999 Osteogenesis imperfecta calls for caution. Nat Med 5:466-467
46. Friedenstein AJ, Chailakhyan RK, Gerasimov UV 1987 Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263-272
47. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG 1997 Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:1059-1069
48. Rombouts WJ, Ploemacher RE 2003 Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17:160-170
49. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R 2000 Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28:707-715
50. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J 2005 Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106:4057-4065
51. Poggi A, Prevosto C, Massaro AM, Negrini S, Urbani S, Pierri I, Saccardi R, Gobbi M, Zocchi MR 2005 Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors. J Immunol 175:6352-6360
52. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L 2006 Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484-1490
53. Lteif AN, Zimmerman D 1998 Bisphosphonates for treatment of childhood hypercalcemia. Pediatrics 102:990-993
54. Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G 1998 Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22:455-461
55. McCarthy EA, Raggio CL, Hossack MD, Miller EA, Jain S, Boskey AL, Camacho NP 2002 Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res 52:660-670
56. Fleisch H, Reszka A, Rodan G, Rogers M 2002 Bisphosphonates: mechanisms of action. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. 2nd ed. San Diego: Academic Press; 1361-1385
57. Fleisch H 1998 Bisphosphonates: mechanisms of action. Endocr Rev 19:80-100
58. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM 2000 Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316
59. Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED 1999 Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol 27:1569-1575
60. + cells in NOD/SCID mice. Exp Hematol 30:870-878
61. Grewal SS, Krivit W, Defor TE, Shapiro EG, Orchard PJ, Abel SL, Lockman LA, Ziegler RS, Dusenbery KE, Peters C 2002 Outcome of second hematopoietic cell transplantation in Hurler syndrome. Bone Marrow Transplant 29:491-496
62. Sodani P, Gaziev D, Polchi P, Erer B, Giardini C, Angelucci E, Baronciani D, Andreani M, Manna M, Nesci S, Lucarelli B, Clift RA, Lucarelli G 2004 New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 104:1201-1203
63. Kraus AB, Shaffer J, Toh HC, Preffer F, Dombkowski D, Saidman S, Colby C, George R, McAfee S, Sackstein R, Dey B, Spitzer TR, Sykes M 2003 Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol 31:609-621
64. Chklovskaia E, Nowbakht P, Nissen C, Gratwohl A, Bargetzi M, Wodnar-Filipowicz A 2004 Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand. Blood 103:3860-3868
65. Roth C, Carlyle JR, Takizawa H, Raulet DH 2000 Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 13:143-153
66. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, Urbani E, Negrin RS, Martelli MF, Velardi A 1999 Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94:333-339
67. Gurevitch O, Prigozhina TB, Pugatsch T, Slavin S 1999 Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment. Transplantation 68:1362-1368
68. Westerhuis G, Maas WGE, Willemze R, Toes REM, Fibbe WE 2005 Longterm mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 106:2215-2220
69. Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, Miller JS 2005 KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 106:4370-4376
70. Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ, Mohanakumar T, Rao A, Hayashi RJ 2005 A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 35:345-352
71. Bianco P, Riminucci M, Gronthos S, Robey PG 2001 Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192